Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome: Pathophysiology and Management

Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome: Pathophysiology and Management

Identification: nnj_ma02A4
Issue: March-April 2002
Volume: Vol. 29, No. 2

Standard: $30.00

Description

This article is available to members for free.

Goal: Discuss the history, pathophysiology, clinical presentation, and current strategies to facilitate positive outcomes in the management of patients with thrombotic thrombocytopenic purpurahemolytic uremic syndrome (TTP-HUS).

Objectives:

  1. Review the pathophysiology, and clinical presentation of TTP-HUS.
  2. Identify current practice strategies and standards utilized in the treatment of TTP-HUS.
  3. Discuss the role of therapeutic plasma exchange as an extracorporeal therapy utilized in the treatment of TTP-HUS.


Author(s)

Credits

Credits: None available.

You must be logged in and own this product in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
* - Indicates answer is required.
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content